These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20166509)

  • 61. Federal 340B Program Payment Scheme for Drugs Designated As Orphan Products: Congressional Clarification Needed to Close the Government-Industry Revolving Door.
    Yang YT; Chen B; Bennett CL
    J Clin Oncol; 2016 Dec; 34(36):4320-4322. PubMed ID: 27998222
    [No Abstract]   [Full Text] [Related]  

  • 62. REMS violations fines.
    Shaffer C
    Nat Biotechnol; 2009 Dec; 27(12):1068. PubMed ID: 20010568
    [No Abstract]   [Full Text] [Related]  

  • 63. Gangrene after penicillin injection (a case report).
    Ozel A; Yavuz H; Erkul I
    Turk J Pediatr; 1995; 37(1):67-71. PubMed ID: 7732611
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 65. In brief: intravenous ondanstron (Zofran) 32 mg withdrawn.
    Med Lett Drugs Ther; 2012 Dec; 54(1406):104. PubMed ID: 23282793
    [No Abstract]   [Full Text] [Related]  

  • 66. Effect of drug industry marketing practices on formularies questioned by federal agencies.
    Gatty B
    Hosp Formul; 1994 Nov; 29(11):786, 785. PubMed ID: 10138576
    [No Abstract]   [Full Text] [Related]  

  • 67. Limiting State Flexibility in Drug Pricing.
    Bagley N; Sachs RE
    N Engl J Med; 2018 Sep; 379(11):1002-1004. PubMed ID: 30207910
    [No Abstract]   [Full Text] [Related]  

  • 68. Four-extremity radiation necrosis. Surgical management.
    Schenck RR; Gilberti MV
    Arch Surg; 1970 Jun; 100(6):729-34. PubMed ID: 5444495
    [No Abstract]   [Full Text] [Related]  

  • 69. Promega changes tack in battle over patent.
    Knight J
    Nature; 2003 Nov; 426(6965):373. PubMed ID: 14647346
    [No Abstract]   [Full Text] [Related]  

  • 70. Inadvertent intra-arterial injection of flucloxacillin.
    Zideman DA; Morgan M
    Anaesthesia; 1981 Mar; 36(3):296-8. PubMed ID: 7224122
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The risk of risk reduction: can postmarket surveillance pose more risk than benefit?
    Hall RF
    Food Drug Law J; 2007; 62(3):473-92. PubMed ID: 17915389
    [No Abstract]   [Full Text] [Related]  

  • 72. Promethazine adverse events after implementation of a medication shortage interchange.
    Sheth HS; Verrico MM; Skledar SJ; Towers AL
    Ann Pharmacother; 2005 Feb; 39(2):255-61. PubMed ID: 15644479
    [TBL] [Abstract][Full Text] [Related]  

  • 73. User-fee bill passes US Senate, but legislative hurdles remain.
    Fox JL
    Nat Biotechnol; 2007 Jun; 25(6):611. PubMed ID: 17557086
    [No Abstract]   [Full Text] [Related]  

  • 74. Fifty years of cosmetic safety: a government and industry partnership.
    Donegan TJ
    Food Drug Law J; 1995; 50 Spec():151-62. PubMed ID: 10343040
    [No Abstract]   [Full Text] [Related]  

  • 75. A patient's right of privacy in computerized pharmacy records.
    Mowery G
    Univ Cincinnati Law Rev; 1998; 66(2):697-746. PubMed ID: 16211743
    [No Abstract]   [Full Text] [Related]  

  • 76. [Long QT syndrome].
    Zbinden S
    Anaesthesist; 2006 Sep; 55(9):1006-7; author reply 1007-8. PubMed ID: 16897019
    [No Abstract]   [Full Text] [Related]  

  • 77. Corporate responsibility for recombinant DNA activities.
    Berger BA
    Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592
    [No Abstract]   [Full Text] [Related]  

  • 78. Colacicco v Apotex Inc. and the federal preemption of state tort remedies for health injuries: implications for public health policy and practice.
    Burke T
    Public Health Rep; 2009; 124(1):160-3. PubMed ID: 19413038
    [No Abstract]   [Full Text] [Related]  

  • 79. Drug review "behind the curtain": a response to Professor Struve.
    O'Reilly JT
    Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971
    [No Abstract]   [Full Text] [Related]  

  • 80. Brand biologics grab 12 years' exclusivity, for now.
    Osborne R
    Nat Biotechnol; 2009 Aug; 27(8):677-8. PubMed ID: 19668153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.